List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of T-Cell Leukemia to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of T-Cell Leukemia to Oncology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in T-Cell Leukemia Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on T-Cell Leukemia 36
Nov 06, 2019: Daiichi Sankyo showcases data presentations on valemetostat at American Society of Hematology (ASH) 36
Clinical Trial Profile Snapshots 37
Appendix 225
Abbreviations 225
Definitions 225
Research Methodology 226
Secondary Research 226
About GlobalData 227
Contact Us 227
Disclaimer 227
Source 228

List of Tables
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2019* 8
T-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
T-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
T-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
T-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
T-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 15
T-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
Proportion of T-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2019* 17
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of T-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2019* 21
T-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
T-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2019* 24
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
T-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
T-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 30
T-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
T-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
T-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35

List of Figures
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
T-Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
T-Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
T-Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
T-Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
T-Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 15
T-Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 16
Proportion of T-Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2019* 17
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
T-Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of T-Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2019* 21
T-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
T-Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24
T-Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25
T-Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26
T-Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
T-Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
T-Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 30
T-Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31
T-Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 33
T-Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
GlobalData Methodology 226

Companies Mentioned
- Bristol-Myers Squibb Co
- Kirin Holdings Co Ltd
- BioCryst Pharmaceuticals Inc
- Novartis AG
- GlaxoSmithKline Plc
- Seattle Genetics Inc
- Bioniz Therapeutics Inc
- Spectrum Pharmaceuticals Inc
- Takeda Pharmaceutical Co Ltd
- AbbVie Inc